It would take a brave business person to swap roles with Adar Poonawalla. The Pune-based Serum Institute of India that his family owns and he runs as its chief executive was served a legal notice last week by AstraZeneca for vaccine supply delays. Reportedly, it must supply 550 million doses to Covax, a global initiative for the equitable distribution of …
India's drug regulator Drugs Controller General of India has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date. In a letter to the Serum Institute of India, Drugs Controller General of India V G Somani said the SII is permitted to apply the shelf life of nine months to unlabelled …
Covishield, the Covid-19 vaccine developed by Pune-based Serum Institute of India and AstraZeneca-Oxford University is on verge of getting emergency approval in India for distribution among at-risk personnel. The institute’s CEO Adar Poonawalla took Rahul Kanwal for an exclusive walkabout around the Covishield factory to show and explain the process behind the production of the Covid vaccine. Adar Poonawalla said …
